Supplementary Table S4 from Defining Non–small Cell Lung Cancer Tumor Microenvironment Changes at Primary and Acquired Immune Checkpoint Inhibitor Resistance Using Clinical and Real-World Data

Baseline gene expression with significant association with ICI treatment outcome (OS) in PD-L1 negative in both CANOPY-1 and Tempus cohort 1 patients